ONWARD Medical

ONWARD Medical is a commercial-stage medical device company with a mission to enable people with spinal cord injury to enjoy life through its ARC neurostimulation platform. Its lead product, the ARC EX System, is FDA-cleared and CE-marked to improve hand and arm function, supported by pivotal trial data published in Nature Medicine. The company's strategy leverages a dual-platform approach—non-invasive and implantable—to address a wide spectrum of SCI-related deficits, including mobility, blood pressure regulation, and bladder control, positioning it at the forefront of a transformative shift in neurological rehabilitation.

The ARC platform delivers targeted, programmed electrical stimulation to the spinal cord via non-invasive (transcutaneous) and implantable (epidural) systems to modulate neural circuits and restore motor, sensory, and autonomic functions.